Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) General Counsel Martin Wilson Sells 1,048 Shares

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) General Counsel Martin Wilson sold 1,048 shares of Rocket Pharmaceuticals stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $23.35, for a total transaction of $24,470.80. Following the completion of the transaction, the general counsel now directly owns 65,762 […]

Related Keywords

Texas ,United States ,America ,Zurcher Kantonalbank Zurich Cantonalbank ,Martin Wilson ,Cantor Fitzgerald ,Jpmorgan Chase Co ,Needham Company ,Asset Management North America Corp ,Rocket Pharmaceuticals Stock Performance ,York Mellon Corp ,Allspring Global Investments Holdings ,Quarter For Rocket Pharmaceuticals ,Nasdaq ,Rocket Pharmaceuticals Inc ,Securities Exchange Commission ,Institutional Trading Of Rocket Pharmaceuticals ,Rocket Pharmaceuticals ,News Ratings For Rocket Pharmaceuticals Daily ,Get Free Report ,General Counsel Martin Wilson ,Exchange Commission ,New York Mellon Corp ,Kantonalbank Zurich Cantonalbank ,Global Investments Holdings ,Retirement System ,Management North America ,Rocket Pharmaceuticals Daily ,